全文获取类型
收费全文 | 4044篇 |
免费 | 84篇 |
国内免费 | 26篇 |
出版年
2023年 | 23篇 |
2022年 | 31篇 |
2021年 | 34篇 |
2020年 | 49篇 |
2019年 | 46篇 |
2018年 | 53篇 |
2017年 | 29篇 |
2016年 | 48篇 |
2015年 | 41篇 |
2014年 | 55篇 |
2013年 | 193篇 |
2012年 | 53篇 |
2011年 | 332篇 |
2010年 | 262篇 |
2009年 | 356篇 |
2008年 | 275篇 |
2007年 | 267篇 |
2006年 | 265篇 |
2005年 | 261篇 |
2004年 | 304篇 |
2003年 | 89篇 |
2002年 | 168篇 |
2001年 | 57篇 |
2000年 | 51篇 |
1999年 | 66篇 |
1998年 | 133篇 |
1997年 | 49篇 |
1996年 | 74篇 |
1995年 | 146篇 |
1994年 | 65篇 |
1993年 | 17篇 |
1992年 | 34篇 |
1991年 | 15篇 |
1990年 | 22篇 |
1989年 | 15篇 |
1988年 | 14篇 |
1987年 | 17篇 |
1986年 | 9篇 |
1985年 | 10篇 |
1984年 | 17篇 |
1983年 | 16篇 |
1982年 | 22篇 |
1981年 | 9篇 |
1980年 | 14篇 |
1979年 | 15篇 |
1978年 | 10篇 |
1977年 | 6篇 |
1976年 | 6篇 |
1975年 | 5篇 |
1974年 | 3篇 |
排序方式: 共有4154条查询结果,搜索用时 500 毫秒
91.
A trypsin and chymotrypsin inhibitor was partially purified from Bauhenia purpurea seeds and separated from a second inhibitor by Ecteola cellulose chromatography. The factor inhibited bovine trypsin and chymotrypsin as well as pronase trypsin and elastase. It formed a complex with trypsin and with chymotrypsin, but a ternary complex could not be detected. Differences were detected in the effect on trypsin and on chymotrypsin, although one enzyme interfered with the inhibition of the other. The results obtained point to two active centers on the inhibitor for the trypsin and chymotrypsin inhibition such that the one cannot complex with the inhibitor after this inhibitor had complexed with the other. 相似文献
92.
93.
《Nucleosides, nucleotides & nucleic acids》2013,32(5-8):1285-1288
Abstract To delineate the binding preferences of stereochemically divergent pyrrolidine PNAs, synthesis of all four diastreomeric monomers of I and the systematic complexation studies of the resultant PNAs with complementary DNA/RNA is essential. We herein report the synthesis of trans-L/D-2-(tert-butoxycarbonylaminomethyl)-4-(thymin-1-yl) pyrrolidin-1-yl acetic acids I, their incorporation in PNA oligomers and DNA binding studies will be presented. 相似文献
94.
The reaction of halflanthanidocene aryloxides CpR′Ln(OArtBu,R)2 (Ln = Y, La, Lu; CpR′ = C5Me5, C4Me4H; R = H, Me) and halflanthanidocene alkoxides [(C5Me5)Ln(OCH2CMe3)2]2 (Ln = Y, Lu) with trimethylaluminum (TMA) was investigated. Monomeric CpR′Ln(OArtBu,R)2, derived from the ortho-tBu-substituted OC6H2tBu2-2,6-R-4 (R = H, Me) ligands, form mono(tetramethylaluminate) complexes CpR′Ln(OArtBu,R)(AlMe4) for the smaller lanthanide metal centers yttrium and lutetium. Such an [aryloxide] → [aluminate] ligand exchange was not observed at the larger lanthanum metal center. The mobility of the tetramethylaluminate ligands of complexes CpR′Ln(OArtBu,R)(AlMe4) (Ln = Y, Lu) was examined by variable-temperature (VT) 1H NMR spectroscopy, revealing two signals for bridging and terminal methyl groups at lower temperatures. The treatment of complexes CpR′Ln(OArtBu,R)(AlMe4) with donor solvent d8-THF gave CpR′Ln(OArtBu,R)(Me)(d8-THF)2 (Ln = Y, Lu) with terminal methyl groups, according to a donor-induced aluminate cleavage reaction. Dimeric [(C5Me5)Ln(OCH2CMe3)2]2 (Ln = Y, Lu) was synthesized from (C5Me5)Ln(NiPr2)2(THF) and reacted with two equivalents of TMA per Ln center to yield monomeric bis(TMA) adduct complexes (C5Me5)Ln(OCH2CMe3)2(AlMe3)2(Ln = Y, Lu). VT NMR spectroscopic studies confirmed a high mobility of the Ln(μ-OCH2CMe3)(μ-Me)AlMe2 moieties at an ambient temperature. Both bis(TMA) adduct complexes were characterized by X-ray structure analysis. 相似文献
95.
Sven Larsson 《Inorganica chimica acta》1996,250(1-2):189-193
In most quantum models for the four-site four-electron problem the lowest singlet state has two short and two long bonds in the absence of lattice polarization and is called the resonating valence bond (VB) state. It is shown here that if the lattice polarization is large, the ground state is a ‘negative U’ state with valence disproportionation (for example BaBiO3 with Bi(V) and Bi(III) sites). Furthermore the model shows that the coupling between the pairs on different sites is provided via the VB state. 相似文献
96.
Although the clinical use of immunoassays based on the oxidative‐reduction electrochemiluminescence (ECL) of tris(2,2′‐bipyridine)ruthenium (II)/tri‐n‐propylamine has been a great success, elucidation of the ECL generation mechanism still remains unsatisfactory. We report here our experimental observations of long‐lived luminescence that remains detectable for several seconds after termination of electrochemical heterogeneous oxidation. Long‐lived luminescence was observed in both a surfactant‐free buffer and a surfactant‐containing broadly used commercial buffer under different conditions. The slow decay of emission seems to have been unnoticed in previous ECL mechanistic studies. Within the frame of the reaction schemes so far proposed, its origin is inconclusively ascribed to the reductive‐oxidation process of ruthenium (II) complex, that is Ru(bpy)32+ → Ru(bpy)31+ → Ru(bpy)32+* → Ru(bpy)32+ with the involvement of the tri‐n‐propylamine‐derived radical cation. It is anticipated that long‐lived ECL will suggest a research approach to separate some homogeneous reactions from the complicated reaction system and therefore help to resolve the mechanistic mystery. 相似文献
97.
《Bioorganic & medicinal chemistry》2020,28(18):115673
Transthyretin (TTR) is a ß-sheet-rich homotetrameric protein that transports thyroxine (T4) and retinol both in plasma and in cerebrospinal fluid. TTR also interacts with amyloid-β, playing a protective role in Alzheimer’s disease. Dissociation of the native transthyretin (TTR) tetramer is widely accepted as the critical step in TTR amyloids fibrillogenesis, and is responsible for extracellular deposition of amyloid fibrils. Small molecules, able to bind in T4 binding sites and stabilize the TTR tetramer, are interesting tools to treat and prevent systemic ATTR amyloidosis. We report here the synthesis, in vitro evaluation and three-dimensional crystallographic analyses of new monoaryl-derivatives in complex with TTR. Of the derivatives reported here, the best inhibitor of TTR fibrillogenesis, 1d, exhibits an activity similar to diflunisal. 相似文献
98.
Daniel J. Saltzberg Shruthi Viswanath Ignacia Echeverria Ilan E. Chemmama Ben Webb Andrej Sali 《Protein science : a publication of the Protein Society》2021,30(1):250-261
Biology is advanced by producing structural models of biological systems, such as protein complexes. Some systems are recalcitrant to traditional structure determination methods. In such cases, it may still be possible to produce useful models by integrative structure determination that depends on simultaneous use of multiple types of data. An ensemble of models that are sufficiently consistent with the data is produced by a structural sampling method guided by a data‐dependent scoring function. The variation in the ensemble of models quantified the uncertainty of the structure, generally resulting from the uncertainty in the input information and actual structural heterogeneity in the samples used to produce the data. Here, we describe how to generate, assess, and interpret ensembles of integrative structural models using our open source Integrative Modeling Platform program ( https://integrativemodeling.org ). 相似文献
99.
100.
Beatris Mastelic Nathalie Garçon Giuseppe Del Giudice Hana Golding Marion Gruber Pieter Neels Bernard Fritzell 《Biologicals》2013,41(6):458-468
Vaccination represents one of the greatest public health triumphs; in part due to the effect of adjuvants that have been included in vaccine preparations to boost the immune responses through different mechanisms. Although a variety of novel adjuvants have been under development, only a limited number have been approved by regulatory authorities for human vaccines. This report reflects the conclusions of a group of scientists from academia, regulatory agencies and industry who attended a conference on the current state of the art in the adjuvant field. Held at the U.S. Pharmacopeial Convention (USP) in Rockville, Maryland, USA, from 18 to 19 April 2013 and organized by the International Association for Biologicals (IABS), the conference focused particularly on the future development of effective adjuvants and adjuvanted vaccines and on overcoming major hurdles, such as safety and immunogenicity assessment, as well as regulatory scrutiny. More information on the conference output can be found on the IABS website, http://www.iabs.org/. 相似文献